JPMorgan Chase Trims Stake in Rayonier Advanced Materials

The financial services giant reduced its holdings in the specialty bioproducts company by 14.1% in the third quarter.

Apr. 3, 2026 at 9:05am

Got story updates? Submit your updates here. ›

A high-contrast, black-and-white close-up image of various industrial banking components like gears, pulleys, and levers, conceptually representing the tangible mechanics and institutional power of the financial sector.A dramatic close-up of the inner workings of the financial industry reveals the heavy machinery and infrastructure that underpins global banking and investment.Today in Jacksonville

JPMorgan Chase & Co. trimmed its position in shares of Rayonier Advanced Materials Inc. (NYSE:RYAM) by 14.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 595,235 shares of the basic materials company's stock after selling 97,508 shares during the quarter.

Why it matters

This move by one of the world's largest investment banks provides insight into the market's sentiment towards Rayonier Advanced Materials, a specialty bioproducts company focused on high-purity cellulose and engineered wood products. The reduced stake could signal broader concerns about the company's performance or outlook.

The details

JPMorgan Chase & Co. now owns about 0.89% of Rayonier Advanced Materials after the reduction in its position. Other major institutional investors, including Millennium Management LLC and UBS Group AG, also made changes to their RYAM holdings during the third quarter.

  • JPMorgan Chase & Co. reduced its stake in Rayonier Advanced Materials during the 3rd quarter of 2026.

The players

JPMorgan Chase & Co.

A multinational financial services firm and one of the largest investment banks in the world.

Rayonier Advanced Materials Inc.

A specialty bioproducts company focused on the production of high-purity cellulose and engineered wood products.

Got photos? Submit your photos here. ›

The takeaway

This move by a major financial institution like JPMorgan Chase could signal broader concerns about Rayonier Advanced Materials' performance or outlook, though the company's specific fundamentals and future prospects remain to be seen. Investors will likely watch closely to see if other large institutional investors follow suit or maintain their positions in the specialty bioproducts firm.